PRESS RELEASE published on 04/23/2025 at 18:59, 1 year ago AB Science announces that EMA granted orphan drug status to AB8939 for the treatment of acute myeloid leukemia AB Science's AB8939 granted orphan drug designation by EMA in EU for treating acute myeloid leukemia, showing significant benefit over current therapies. Preclinical data reveals efficacy and safety Orphan Drug Designation AB Science EMA AB8939 Acute Myeloid Leukemia
PRESS RELEASE published on 04/23/2025 at 18:47, 1 year ago Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces purchase of own shares as part of buyback program on 23-Apr-2025. Details of shares bought and voting rights disclosed Voting Rights London Stock Exchange Share Buyback Program Fuller, Smith & Turner PLC Own Shares
REGULATED PRESS RELEASE published on 04/23/2025 at 18:39, 1 year ago Derichebourg announces its financial calendar for 2024/2025 financial year Derichebourg announces its financial calendar for 2024/2025 financial year. Events include half-year and full-year results, AGM dates. Derichebourg Group is a leader in metal recycling and environmental services Financial Calendar 2024/2025 Environmental Services Derichebourg Metal Recycling
PRESS RELEASE published on 04/23/2025 at 18:30, 1 year ago Fermentalg provides an update on the status of its natural blue dye approval by the U.S. FDA. Fermentalg provides update on FDA approval of natural blue dye, aligning with trend of replacing synthetic food colorings with natural alternatives derived from aquatic microorganisms FDA Approval Sustainable Solutions FERMENTALG Aquatic Microorganisms Natural Blue Dye
PRESS RELEASE published on 04/23/2025 at 18:23, 1 year ago EQS-Adhoc: adidas brand momentum drives better-than-expected first quarter results adidas reports strong first quarter results with revenue growth and improved gross margin, driven by brand momentum. Final financial results to be announced on April 29, 2025 Revenue Growth Gross Margin Quarter Results Adidas Brand Momentum
REGULATED PRESS RELEASE published on 04/23/2025 at 18:17, 1 year ago Disclosure of trading in own shares between April 14th and April 17th, 2025 Derichebourg discloses own shares purchases between April 14th and 17th, 2025 for shares cancellation. More info on website. Derichebourg: major operator in environmental services Revenue Own Shares Purchases Environmental Services Derichebourg
PRESS RELEASE published on 04/23/2025 at 18:00, 1 year ago First-quarter 2025 revenue: EUR 136.2 million Strong resilience overall despite negative calendar effects Aubay reports Q1 2025 revenue down 3.0% at €136.2 million. Pricing trended up globally offsetting international headcount decline. The Group anticipates an upward demand in 2025 Revenue International Demand Aubay Q1 2025 Pricing Trend
PRESS RELEASE published on 04/23/2025 at 17:53, 1 year ago Elis: Disclosure of the number of shares forming the capital and of the total number of voting rights as of 31 03 2025 Elis SA discloses the number of shares forming the capital and the total voting rights as of 31 March 2025. Details available on www.elis.com Voting Rights Shares Investor Relations Disclosure Elis SA
PRESS RELEASE published on 04/23/2025 at 17:46, 1 year ago JCDecaux : Information concerning the availability of all the explanatory documentation to the Combined General Meeting to be held on May 14, 2025 The notice provides details of the availability of all explanatory documentation for the Combined General Meeting on May 14, 2025, including webcast and document access Shareholders Webcast General Meeting JCDecaux Documentation Availability
REGULATED PRESS RELEASE published on 04/23/2025 at 17:45, 1 year ago CRIT : First quarter 2025 revenue: € 766.1 million (+31.0%) Groupe CRIT reports 31.0% revenue growth in Q1 2025 driven by Temporary Work and Airport services, with 45% of turnover from outside France Groupe CRIT Revenue Growth Temporary Work Airport Services Q1 2025
Published on 04/29/2026 at 02:25, 1 hour 18 minutes ago Organto Foods Announces Fiscal 2025 Financial Results
Published on 04/29/2026 at 00:20, 3 hours 23 minutes ago Fountain Asset Corp. Announces Its Financial Results for the Quarter and Year Ended December 31, 2025
Published on 04/29/2026 at 00:00, 3 hours 43 minutes ago LIR Life Sciences Launches Ex Vivo Animal Study to Evaluate Protamine Enhanced Transdermal Transport of Larger Format Therapeutic Molecules
Published on 04/29/2026 at 00:00, 3 hours 43 minutes ago Onco-Innovations Announces Successful Scale-Up of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for its PNKP Inhibitor Technology Program
Published on 04/28/2026 at 22:15, 5 hours 28 minutes ago Preliminary figures confirmed by final financial statements 2025
Published on 04/28/2026 at 21:55, 5 hours 48 minutes ago Piramal Pharma Limited Announces Results for Q4 and Full-year FY26
Published on 04/28/2026 at 21:00, 6 hours 43 minutes ago VAT Group AG Annual General Meeting 2026: Shareholders approved all Board proposals and a dividend increase of 12% to CHF 7.00 per share
Published on 04/28/2026 at 19:53, 7 hours 49 minutes ago EQS-Adhoc: Scout24 SE resolves to launch a second tranche of its share buy-back programme of up to EUR 250 million in 2026 and to shorten the buy-back period of the ongoing tranche
Published on 04/28/2026 at 19:20, 8 hours 23 minutes ago CGTN: What China's strong start to the 15th FYP period signals
Published on 04/28/2026 at 18:00, 9 hours 43 minutes ago LDC has received approval from the Competition and Markets Authority (CMA) for the acquisition of shares in Green Label
Published on 04/28/2026 at 17:57, 9 hours 46 minutes ago Peugeot Invest enters into an agreement to sell its stake in Immobilière Dassault for €75 million
Published on 04/28/2026 at 17:45, 9 hours 58 minutes ago ALTAREA : Financial and business information at 31 March 2026